AdaptHealth Corp.: Slimming Down Following The Sale Of The Diabetes Business
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T14:50:02.000Z","dateModified":"2026-07-24T14:52:59.000Z","description":"AdaptHealth sells diabetes business to Cardinal Health for $235M, cutting debt and refocusing on sleep/respiratory. Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T14:50:02.000Z","dateModified":"2026-07-24T14:52:59.000Z","description":"AdaptHealth sells diabetes business to Cardinal Health for $235M, c
- ▪Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate.
Seeking Alpha files mainly under finance. We currently carry 6,165 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4925309-adapthealth-corp-slimming-down-following-the-sale-of-the-diabetes-business"},"author":{"@type":"Person","name":"The Value Investor","url":"https://seekingalpha.com/author/the-value-investor"},"publisher":{"@context":"https://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
